- Hologic Announces Financial Results for Second Quarter of Fiscal 2024
- Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
More ▼
Key statistics
On Thursday, Hologic Inc (HOLX:NSQ) closed at 75.91, -12.49% below its 52-week high of 86.74, set on May 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 76.53 |
---|---|
High | 76.70 |
Low | 75.13 |
Bid | 30.52 |
Offer | 89.00 |
Previous close | 75.91 |
Average volume | 1.30m |
---|---|
Shares outstanding | 234.73m |
Free float | 233.00m |
P/E (TTM) | 36.09 |
Market cap | 17.82bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of May 02 2024 21:00 BST.
More ▼